Developing biomarkers that PREdict bone metastasis
Inbiomotion has raised €2.1M across 1 funding round from 1 investor, most recently a Seed round in Jun 2012. Based in Barcelona, Spain; founded 2010; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-06-01 | Seed | €2.1M |
| Ysios Capital |
| View deal → |
